The course “Translational study and research of pharmacology” is a newly evolved lecture as an extension from basic knowledge of pharmacology to clinical application in translating innovations, new therapies, as well as novel diagnostics to specific teaching contents. The basic objective of this course is to study the changing trends from experimental and preclinical studies to clinical pharmacology. And, the course aims to provide the most updated information of new drugs development, including nucleic acid drugs and cellular therapies, and human disease modeling, and to cultivate students who would like to devote themselves to academic institutes or pharmaceutical industry in the future. We provide brief but fundamental knowledge in the pathogenesis of human diseases, and identify novel therapeutic targets which are actively explored by pharmaceutical industry to develop potential therapeutic agents either in the pre-clinical stage or under clinical trials. The pharmacology, toxicology and unmet medical needs of these drugs and new therapies will be discussed. We would also provide TFDA Regulations and Guidance for Investigational New Drug (IND) and New Drug Application (NDA). Thus, we expect that “Translational study and research of pharmacology” will bridge the gap between the basic pharmacology to the clinical application. Therefore, it helps in translating the knowledge from the basic knowledge to the bedside patient studies.